|
T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Pipeline Review, H2 2018 |
Nov 20 2018 |
77 |
Global |
$3,500.00 |
|
|
Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H2 2018 |
Nov 20 2018 |
57 |
Global |
$3,500.00 |
|
|
Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Pipeline Review, H2 2018 |
Nov 20 2018 |
67 |
Global |
$3,500.00 |
|
|
Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Pipeline Review, H2 2018 |
Nov 20 2018 |
35 |
Global |
$3,500.00 |
|
|
Radiodermatitis - Pipeline Review, H2 2018 |
Nov 20 2018 |
36 |
Global |
$2,000.00 |
|
|
Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H2 2018 |
Nov 20 2018 |
48 |
Global |
$3,500.00 |
|
|
Diabetic Foot Ulcers - Pipeline Review, H2 2018 |
Nov 20 2018 |
138 |
Global |
$2,000.00 |
|
|
cAMP and cAMP Inhibited cGMP 3',5' Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H2 2018 |
Nov 20 2018 |
36 |
Global |
$3,500.00 |
|
|
Wilms Tumor Protein (WT33 or WT1) - Pipeline Review, H2 2018 |
Nov 20 2018 |
68 |
Global |
$3,500.00 |
|
|
T Lymphocyte Activation Antigen CD80 (Activation B7-1 Antigen or CTLA 4 Counter Receptor B7.1 or CD80) - Pipeline Review, H2 2018 |
Nov 20 2018 |
79 |
Global |
$3,500.00 |
|
|
Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) - Pipeline Review, H2 2018 |
Nov 20 2018 |
32 |
Global |
$3,500.00 |
|
|
Spinocerebellar Ataxia (SCA) - Pipeline Review, H2 2018 |
Nov 13 2018 |
71 |
Global |
$2,000.00 |
|
|
Secondary (Hypogonadotropic) Hypogonadism - Pipeline Review, H2 2018 |
Nov 13 2018 |
63 |
Global |
$2,000.00 |
|
|
Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Pipeline Review, H2 2018 |
Nov 13 2018 |
185 |
Global |
$3,500.00 |
|
|
Hypothyroidism - Pipeline Review, H2 2018 |
Nov 13 2018 |
30 |
Global |
$2,000.00 |
|
|
Progressive Multifocal Leukoencephalopathy - Pipeline Review, H2 2018 |
Nov 13 2018 |
29 |
Global |
$2,000.00 |
|
|
Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2018 |
Nov 13 2018 |
123 |
Global |
$3,500.00 |
|
|
Anaphylaxis - Pipeline Review, H2 2018 |
Nov 13 2018 |
36 |
Global |
$2,000.00 |
|
|
Systemic Mastocytosis - Pipeline Review, H2 2018 |
Nov 13 2018 |
169 |
Global |
$2,000.00 |
|
|
Tumor Necrosis Factor Receptor Superfamily Member 6 (Apo 1 Antigen or Apoptosis Mediating Surface Antigen FAS or FASLG Receptor or TNFRSF6 or CD95 or FAS) - Pipeline Review, H2 2018 |
Nov 13 2018 |
39 |
Global |
$3,500.00 |
|
|
Fanconi Anemia - Pipeline Review, H2 2018 |
Nov 13 2018 |
53 |
Global |
$2,000.00 |
|
|
Peritonitis - Pipeline Review, H2 2018 |
Nov 13 2018 |
36 |
Global |
$2,000.00 |
|
|
RAC Beta Serine/Threonine Protein Kinase (Protein Kinase Akt 2 or Protein Kinase B Beta or RAC PK Beta or AKT2 or EC 2.7.11.1) - Pipeline Review, H2 2018 |
Nov 13 2018 |
69 |
Global |
$3,500.00 |
|
|
Macular Edema - Pipeline Review, H2 2018 |
Nov 13 2018 |
50 |
Global |
$2,000.00 |
|
|
Irritable Bowel Syndrome - Pipeline Review, H2 2018 |
Nov 13 2018 |
132 |
Global |
$2,000.00 |
|
|
Hypoxia Inducible Factor 1 Alpha (ARNT Interacting Protein or Basic Helix Loop Helix PAS Protein MOP1 or Class E Basic Helix Loop Helix Protein 78 or Member Of PAS Protein 1 or PAS Domain Containing Protein 8 or HIF1A) - Pipeline Review, H2 2018 |
Nov 13 2018 |
73 |
Global |
$3,500.00 |
|
|
Aplastic Anemia - Pipeline Review, H2 2018 |
Nov 13 2018 |
80 |
Global |
$2,000.00 |
|
|
T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H2 2018 |
Nov 13 2018 |
50 |
Global |
$3,500.00 |
|
|
Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H2 2018 |
Nov 13 2018 |
73 |
Global |
$3,500.00 |
|
|
Lung Transplant Rejection - Pipeline Review, H2 2018 |
Nov 13 2018 |
73 |
Global |
$2,000.00 |
|
